Predicting risk of ovulation in new start oral contraceptive users

Jill L. Schwartz, Mitchell D Creinin, Helen C. Pymar, Lynn Reid

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

OBJECTIVE: To assess ovarian follicular development and ovulation rates in women starting to take oral contraceptives (OC) on menstrual cycle day 1, 4, or 7. METHODS: One hundred thirty women starting treatment with OC were randomized to begin use of ethinyl estradiol, 30 μg, plus norgestrel, 300 μg, on menstrual cycle day 1 (group 1), 4 (group 2), or 7 (group 3). Follicular development was assessed by vaginal ultrasonography on menstrual cycle days 7, 14, 21, and 28, and serum progesterone levels were measured on menstrual cycle days 21 and 28. At a .05 level of significance (two-tailed) and power of 80%, 84 participants were required to complete the study. Eighty-five women who met study criteria, made minimal dosing errors, and underwent at least three ultrasonographic examinations were analyzed. RESULTS: A follicle-like structure that reached a maximum diameter over 13 mm was observed in three of 29 (10.3%), five of 29 (17.2%), and 12 of 27 (44.4%) women in groups 1, 2 and 3, respectively (P = 0.003). The median maximum follicle size for each group was 9.0 mm, 9.0 mm, and 12.0 mm for start day 1, 4, and 7 respectively (P < .001). Evidence of ovulation based on serum progesterone was present in two, one, and zero women in groups 1, 2, and 3, respectively (P = .2). CONCLUSION: Although a delay in oral contraceptive initiation results in significantly more ovarian follicular development, the postponement does not appear to increase actual ovulation rates.

Original languageEnglish (US)
Pages (from-to)177-182
Number of pages6
JournalObstetrics and Gynecology
Volume99
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Ovulation Prediction
Oral Contraceptives
Menstrual Cycle
Ovulation
Progesterone
Norgestrel
Ethinyl Estradiol
Serum
Ultrasonography

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Predicting risk of ovulation in new start oral contraceptive users. / Schwartz, Jill L.; Creinin, Mitchell D; Pymar, Helen C.; Reid, Lynn.

In: Obstetrics and Gynecology, Vol. 99, No. 2, 2002, p. 177-182.

Research output: Contribution to journalArticle

Schwartz, Jill L. ; Creinin, Mitchell D ; Pymar, Helen C. ; Reid, Lynn. / Predicting risk of ovulation in new start oral contraceptive users. In: Obstetrics and Gynecology. 2002 ; Vol. 99, No. 2. pp. 177-182.
@article{1ddc40348a854b7ebe894467b7d21301,
title = "Predicting risk of ovulation in new start oral contraceptive users",
abstract = "OBJECTIVE: To assess ovarian follicular development and ovulation rates in women starting to take oral contraceptives (OC) on menstrual cycle day 1, 4, or 7. METHODS: One hundred thirty women starting treatment with OC were randomized to begin use of ethinyl estradiol, 30 μg, plus norgestrel, 300 μg, on menstrual cycle day 1 (group 1), 4 (group 2), or 7 (group 3). Follicular development was assessed by vaginal ultrasonography on menstrual cycle days 7, 14, 21, and 28, and serum progesterone levels were measured on menstrual cycle days 21 and 28. At a .05 level of significance (two-tailed) and power of 80{\%}, 84 participants were required to complete the study. Eighty-five women who met study criteria, made minimal dosing errors, and underwent at least three ultrasonographic examinations were analyzed. RESULTS: A follicle-like structure that reached a maximum diameter over 13 mm was observed in three of 29 (10.3{\%}), five of 29 (17.2{\%}), and 12 of 27 (44.4{\%}) women in groups 1, 2 and 3, respectively (P = 0.003). The median maximum follicle size for each group was 9.0 mm, 9.0 mm, and 12.0 mm for start day 1, 4, and 7 respectively (P < .001). Evidence of ovulation based on serum progesterone was present in two, one, and zero women in groups 1, 2, and 3, respectively (P = .2). CONCLUSION: Although a delay in oral contraceptive initiation results in significantly more ovarian follicular development, the postponement does not appear to increase actual ovulation rates.",
author = "Schwartz, {Jill L.} and Creinin, {Mitchell D} and Pymar, {Helen C.} and Lynn Reid",
year = "2002",
doi = "10.1016/S0029-7844(01)01676-3",
language = "English (US)",
volume = "99",
pages = "177--182",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Predicting risk of ovulation in new start oral contraceptive users

AU - Schwartz, Jill L.

AU - Creinin, Mitchell D

AU - Pymar, Helen C.

AU - Reid, Lynn

PY - 2002

Y1 - 2002

N2 - OBJECTIVE: To assess ovarian follicular development and ovulation rates in women starting to take oral contraceptives (OC) on menstrual cycle day 1, 4, or 7. METHODS: One hundred thirty women starting treatment with OC were randomized to begin use of ethinyl estradiol, 30 μg, plus norgestrel, 300 μg, on menstrual cycle day 1 (group 1), 4 (group 2), or 7 (group 3). Follicular development was assessed by vaginal ultrasonography on menstrual cycle days 7, 14, 21, and 28, and serum progesterone levels were measured on menstrual cycle days 21 and 28. At a .05 level of significance (two-tailed) and power of 80%, 84 participants were required to complete the study. Eighty-five women who met study criteria, made minimal dosing errors, and underwent at least three ultrasonographic examinations were analyzed. RESULTS: A follicle-like structure that reached a maximum diameter over 13 mm was observed in three of 29 (10.3%), five of 29 (17.2%), and 12 of 27 (44.4%) women in groups 1, 2 and 3, respectively (P = 0.003). The median maximum follicle size for each group was 9.0 mm, 9.0 mm, and 12.0 mm for start day 1, 4, and 7 respectively (P < .001). Evidence of ovulation based on serum progesterone was present in two, one, and zero women in groups 1, 2, and 3, respectively (P = .2). CONCLUSION: Although a delay in oral contraceptive initiation results in significantly more ovarian follicular development, the postponement does not appear to increase actual ovulation rates.

AB - OBJECTIVE: To assess ovarian follicular development and ovulation rates in women starting to take oral contraceptives (OC) on menstrual cycle day 1, 4, or 7. METHODS: One hundred thirty women starting treatment with OC were randomized to begin use of ethinyl estradiol, 30 μg, plus norgestrel, 300 μg, on menstrual cycle day 1 (group 1), 4 (group 2), or 7 (group 3). Follicular development was assessed by vaginal ultrasonography on menstrual cycle days 7, 14, 21, and 28, and serum progesterone levels were measured on menstrual cycle days 21 and 28. At a .05 level of significance (two-tailed) and power of 80%, 84 participants were required to complete the study. Eighty-five women who met study criteria, made minimal dosing errors, and underwent at least three ultrasonographic examinations were analyzed. RESULTS: A follicle-like structure that reached a maximum diameter over 13 mm was observed in three of 29 (10.3%), five of 29 (17.2%), and 12 of 27 (44.4%) women in groups 1, 2 and 3, respectively (P = 0.003). The median maximum follicle size for each group was 9.0 mm, 9.0 mm, and 12.0 mm for start day 1, 4, and 7 respectively (P < .001). Evidence of ovulation based on serum progesterone was present in two, one, and zero women in groups 1, 2, and 3, respectively (P = .2). CONCLUSION: Although a delay in oral contraceptive initiation results in significantly more ovarian follicular development, the postponement does not appear to increase actual ovulation rates.

UR - http://www.scopus.com/inward/record.url?scp=0036152905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036152905&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(01)01676-3

DO - 10.1016/S0029-7844(01)01676-3

M3 - Article

C2 - 11814492

AN - SCOPUS:0036152905

VL - 99

SP - 177

EP - 182

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2

ER -